false Q3 --12-31 0001873722 0001873722 2023-01-01 2023-09-30 0001873722 2023-11-14 0001873722 2023-09-30 0001873722 2022-12-31 0001873722 us-gaap:SeriesCPreferredStockMember 2023-09-30 0001873722 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001873722 2023-07-01 2023-09-30 0001873722 2022-07-01 2022-09-30 0001873722 2022-01-01 2022-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-12-31 0001873722 us-gaap:CommonStockMember 2021-12-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2021-12-31 0001873722 us-gaap:RetainedEarningsMember 2021-12-31 0001873722 us-gaap:ComprehensiveIncomeMember 2021-12-31 0001873722 2021-12-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-03-31 0001873722 us-gaap:CommonStockMember 2022-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-03-31 0001873722 us-gaap:RetainedEarningsMember 2022-03-31 0001873722 us-gaap:ComprehensiveIncomeMember 2022-03-31 0001873722 2022-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-06-30 0001873722 us-gaap:CommonStockMember 2022-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-06-30 0001873722 us-gaap:RetainedEarningsMember 2022-06-30 0001873722 us-gaap:ComprehensiveIncomeMember 2022-06-30 0001873722 2022-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-12-31 0001873722 us-gaap:CommonStockMember 2022-12-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-12-31 0001873722 us-gaap:RetainedEarningsMember 2022-12-31 0001873722 us-gaap:ComprehensiveIncomeMember 2022-12-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-03-31 0001873722 us-gaap:CommonStockMember 2023-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-03-31 0001873722 us-gaap:RetainedEarningsMember 2023-03-31 0001873722 us-gaap:ComprehensiveIncomeMember 2023-03-31 0001873722 2023-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-06-30 0001873722 us-gaap:CommonStockMember 2023-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-06-30 0001873722 us-gaap:RetainedEarningsMember 2023-06-30 0001873722 us-gaap:ComprehensiveIncomeMember 2023-06-30 0001873722 2023-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-03-31 0001873722 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-01-01 2022-03-31 0001873722 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001873722 us-gaap:ComprehensiveIncomeMember 2022-01-01 2022-03-31 0001873722 2022-01-01 2022-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2022-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-04-01 2022-06-30 0001873722 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-04-01 2022-06-30 0001873722 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001873722 us-gaap:ComprehensiveIncomeMember 2022-04-01 2022-06-30 0001873722 2022-04-01 2022-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-07-01 2022-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-07-01 2022-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-07-01 2022-09-30 0001873722 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-07-01 2022-09-30 0001873722 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001873722 us-gaap:ComprehensiveIncomeMember 2022-07-01 2022-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-03-31 0001873722 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-01-01 2023-03-31 0001873722 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001873722 us-gaap:ComprehensiveIncomeMember 2023-01-01 2023-03-31 0001873722 2023-01-01 2023-03-31 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-04-01 2023-06-30 0001873722 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-04-01 2023-06-30 0001873722 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001873722 us-gaap:ComprehensiveIncomeMember 2023-04-01 2023-06-30 0001873722 2023-04-01 2023-06-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-07-01 2023-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-07-01 2023-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-07-01 2023-09-30 0001873722 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-07-01 2023-09-30 0001873722 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001873722 us-gaap:ComprehensiveIncomeMember 2023-07-01 2023-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-09-30 0001873722 us-gaap:CommonStockMember 2022-09-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-09-30 0001873722 us-gaap:RetainedEarningsMember 2022-09-30 0001873722 us-gaap:ComprehensiveIncomeMember 2022-09-30 0001873722 2022-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-09-30 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-09-30 0001873722 us-gaap:CommonStockMember 2023-09-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-09-30 0001873722 us-gaap:RetainedEarningsMember 2023-09-30 0001873722 us-gaap:ComprehensiveIncomeMember 2023-09-30 0001873722 BBLR:UWRLMember 2023-09-30 0001873722 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-09-30 0001873722 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-09-30 0001873722 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001873722 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001873722 BBLR:ConvertibleNotesMember 2023-01-01 2023-09-30 0001873722 BBLR:ConvertibleNotesMember 2022-01-01 2022-09-30 0001873722 us-gaap:AutomobilesMember 2022-12-31 0001873722 us-gaap:ComputerEquipmentMember 2022-12-31 0001873722 us-gaap:OfficeEquipmentMember 2022-12-31 0001873722 us-gaap:AutomobilesMember 2023-01-01 2023-09-30 0001873722 us-gaap:ComputerEquipmentMember 2023-01-01 2023-09-30 0001873722 us-gaap:OfficeEquipmentMember 2023-01-01 2023-09-30 0001873722 us-gaap:AutomobilesMember 2023-09-30 0001873722 us-gaap:ComputerEquipmentMember 2023-09-30 0001873722 us-gaap:OfficeEquipmentMember 2023-09-30 0001873722 us-gaap:PatentsMember 2023-09-30 0001873722 us-gaap:IntellectualPropertyMember 2023-09-30 0001873722 BBLR:NewzMineMember 2023-09-30 0001873722 BBLR:NewzMineMember 2022-12-31 0001873722 BBLR:CitizensJournalistMember 2023-09-30 0001873722 BBLR:CitizensJournalistMember 2022-12-31 0001873722 us-gaap:PatentsMember 2022-12-31 0001873722 us-gaap:TrademarksMember 2022-12-31 0001873722 us-gaap:IntellectualPropertyMember 2022-12-31 0001873722 BBLR:CapitalizedAcquisitionCostsMember 2022-12-31 0001873722 us-gaap:PatentsMember 2023-01-01 2023-09-30 0001873722 us-gaap:TrademarksMember 2023-01-01 2023-09-30 0001873722 us-gaap:IntellectualPropertyMember 2023-01-01 2023-09-30 0001873722 BBLR:CapitalizedAcquisitionCostsMember 2023-01-01 2023-09-30 0001873722 us-gaap:TrademarksMember 2023-09-30 0001873722 BBLR:CapitalizedAcquisitionCostsMember 2023-09-30 0001873722 BBLR:WhiteLionNoteMember 2022-02-04 0001873722 BBLR:WhiteLionNoteMember 2022-04-26 2022-04-26 0001873722 BBLR:WhiteLionNoteMember 2022-02-04 2022-02-04 0001873722 BBLR:VehicleMember 2019-11-01 2019-11-30 0001873722 BBLR:VehicleMember 2019-11-30 0001873722 BBLR:ShareholderLoansMember 2022-02-01 2022-02-28 0001873722 BBLR:ShareholderLoansMember 2023-02-15 0001873722 BBLR:ShareholderLoansMember 2023-02-15 2023-02-15 0001873722 BBLR:ShareholderLoansMember 2021-01-01 2021-12-31 0001873722 BBLR:ShareholderLoansMember 2022-04-30 2022-04-30 0001873722 us-gaap:RelatedPartyMember 2023-09-30 0001873722 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001873722 BBLR:ShareholderLoansMember 2023-01-01 2023-09-30 0001873722 BBLR:ShareholderLoansMember 2022-01-01 2022-09-30 0001873722 BBLR:ShareholderLoansMember 2023-09-30 0001873722 BBLR:ShareholderLoansMember 2022-09-30 0001873722 BBLR:FounderLoanMember 2023-09-30 0001873722 BBLR:FounderLoanMember 2022-12-31 0001873722 BBLR:FounderLoanMember 2022-05-23 2022-05-23 0001873722 BBLR:FounderLoanMember 2023-01-01 2023-09-30 0001873722 BBLR:FounderLoanAmendment2Member 2022-09-06 2022-09-06 0001873722 BBLR:FounderLoanAmendment3Member 2022-12-20 2022-12-20 0001873722 BBLR:BubblrLimitedAndMorrisMember 2023-01-01 2023-09-30 0001873722 BBLR:BubblrLimitedAndMorrisMember 2022-01-01 2022-09-30 0001873722 BBLR:BubblrLimitedAndMorrisMember 2022-09-07 0001873722 BBLR:ShareholderLoansMember 2022-12-31 0001873722 BBLR:ShareholderLoansMember 2021-12-31 0001873722 BBLR:ShareholderLoansMember 2022-01-01 2022-12-31 0001873722 BBLR:FounderLoanMember 2021-12-31 0001873722 BBLR:FounderLoanMember 2022-01-01 2022-12-31 0001873722 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2023-09-30 0001873722 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001873722 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2023-09-30 0001873722 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2023-09-30 0001873722 us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001873722 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2023-09-30 0001873722 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2023-09-30 0001873722 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001873722 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001873722 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001873722 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001873722 us-gaap:SeriesCPreferredStockMember 2022-03-04 0001873722 us-gaap:SeriesCPreferredStockMember BBLR:RedeemedAfterNinetyDaysMember 2023-01-01 2023-09-30 0001873722 us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-09-30 0001873722 BBLR:GHSMember 2022-03-04 0001873722 BBLR:Tranche1Member us-gaap:SeriesCPreferredStockMember 2022-03-03 2022-03-04 0001873722 BBLR:GHSMember BBLR:CommitmentSharesMember us-gaap:SeriesCPreferredStockMember 2022-03-03 2022-03-04 0001873722 BBLR:GHSMember 2023-09-30 0001873722 BBLR:GHSMember us-gaap:SeriesCPreferredStockMember 2022-03-04 0001873722 BBLR:GHSMember 2023-01-01 2023-09-30 0001873722 BBLR:ProactiveMember 2022-03-09 0001873722 BBLR:ProactiveMember BBLR:CommitmentSharesMember us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-09-30 0001873722 BBLR:ProactiveMember 2023-09-30 0001873722 BBLR:ProactiveMember us-gaap:SeriesCPreferredStockMember 2023-09-30 0001873722 BBLR:ProactiveMember us-gaap:SeriesCPreferredStockMember 2022-03-07 2022-03-09 0001873722 BBLR:ProactiveTwoMember 2023-01-01 2023-09-30 0001873722 BBLR:GHSTranche2Member us-gaap:SeriesCPreferredStockMember 2022-04-23 2022-04-24 0001873722 BBLR:GHSTranche2Member 2022-04-24 0001873722 BBLR:GHSTranche2Member 2022-04-23 2022-04-24 0001873722 BBLR:GHSTranche3Member us-gaap:SeriesCPreferredStockMember 2022-05-24 2022-05-25 0001873722 BBLR:GHSTranche3Member 2022-05-25 0001873722 BBLR:GHSTranche3Member 2022-05-24 2022-05-25 0001873722 BBLR:GHSTranche4Member us-gaap:SeriesCPreferredStockMember 2022-09-24 2022-09-24 0001873722 BBLR:GHSTranche4Member 2022-09-24 0001873722 BBLR:GHSTranche4Member 2022-09-24 2022-09-24 0001873722 BBLR:BubblrLimitedAndMorrisMember 2023-09-30 0001873722 BBLR:BubblrLimitedAndMorrisMember 2022-09-07 2022-09-07 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-09-07 2022-09-07 0001873722 BBLR:GHSMember 2022-09-07 2022-09-07 0001873722 BBLR:ProactiveMember 2022-09-07 2022-09-07 0001873722 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-09-30 0001873722 BBLR:ProactiveTotalMember 2023-01-01 2023-09-30 0001873722 BBLR:WarrantAllocatedMember 2023-01-01 2023-09-30 0001873722 2022-01-01 2022-12-31 0001873722 BBLR:AdvisoryBoardMember 2022-01-01 2022-09-30 0001873722 BBLR:InvestorRelationsMember 2022-01-01 2022-09-30 0001873722 BBLR:ConsultancyServicesMember 2022-01-01 2022-09-30 0001873722 BBLR:CommitmentSharesToGHSMember 2022-01-01 2022-09-30 0001873722 BBLR:TerminationAgreementWhiteLionMember 2022-01-01 2022-09-30 0001873722 us-gaap:SeriesCPreferredStockMember BBLR:SecuritiesPurchaseAgreementsMember 2022-01-01 2022-09-30 0001873722 BBLR:ConsultancyServicesMember 2023-01-01 2023-09-30 0001873722 BBLR:ProfessionalServicesMember 2023-01-01 2023-09-30 0001873722 BBLR:InvestorRelationsMember 2023-01-01 2023-09-30 0001873722 us-gaap:WarrantMember 2023-09-30 0001873722 BBLR:EquityIncentivePlanMember 2022-05-24 2022-05-25 0001873722 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001873722 BBLR:EquityIncentivePlanMember 2022-01-01 2022-12-31 0001873722 us-gaap:DeferredCompensationShareBasedPaymentsMember 2023-01-01 2023-09-30 0001873722 BBLR:RSUMember 2023-01-29 2023-01-31 0001873722 2023-04-01 2023-04-01 0001873722 BBLR:WhiteLionCapitalMember 2023-01-01 2023-09-30 0001873722 BBLR:WhiteLionCapitalMember 2022-02-01 2022-02-01 0001873722 BBLR:WhiteLionCapitalTerminationIssuanceMember 2022-03-22 2022-03-22 0001873722 BBLR:GHSConsiderationMember BBLR:EquityFinancingAgreementsMember 2022-03-04 0001873722 BBLR:GHSMember 2022-01-01 2022-12-31 0001873722 BBLR:GHSConsiderationMember BBLR:EquityFinancingAgreementsMember 2022-03-04 2022-03-04 0001873722 BBLR:WarrantsOneMember 2023-09-30 0001873722 BBLR:WarrantsOneMember 2023-01-01 2023-09-30 0001873722 BBLR:WarrantsTwoMember 2023-09-30 0001873722 BBLR:WarrantsTwoMember 2023-01-01 2023-09-30 0001873722 BBLR:WarrantsThreeMember 2023-09-30 0001873722 BBLR:WarrantsThreeMember 2023-01-01 2023-09-30 0001873722 BBLR:WarrantsFourMember 2023-09-30 0001873722 BBLR:WarrantsFourMember 2023-01-01 2023-09-30 0001873722 BBLR:WarrantsFiveMember 2023-09-30 0001873722 BBLR:WarrantsFiveMember 2023-01-01 2023-09-30 0001873722 srt:MinimumMember 2023-01-01 2023-09-30 0001873722 srt:MaximumMember 2023-01-01 2023-09-30 0001873722 BBLR:StockOptionOneMember 2023-09-30 0001873722 BBLR:StockOptionOneMember 2023-01-01 2023-09-30 0001873722 BBLR:StockOptionTwoMember 2023-09-30 0001873722 BBLR:StockOptionTwoMember 2023-01-01 2023-09-30 0001873722 BBLR:StockOptionThreeMember 2023-09-30 0001873722 BBLR:StockOptionThreeMember 2023-01-01 2023-09-30 0001873722 BBLR:StockOptionFourMember 2023-09-30 0001873722 BBLR:StockOptionFourMember 2023-01-01 2023-09-30 0001873722 BBLR:StockOptionFiveMember 2023-09-30 0001873722 BBLR:StockOptionFiveMember 2023-01-01 2023-09-30 0001873722 BBLR:ScotlandPremisisMember 2023-01-01 2023-09-30 0001873722 BBLR:ScotlandPremisisMember 2022-01-01 2022-09-30 0001873722 BBLR:ScotlandPremisisMember 2022-07-14 2022-07-14 0001873722 BBLR:VirtualOfficeSpaceMember 2023-01-01 2023-09-30 0001873722 BBLR:NewYorkPremisisMember 2023-01-01 2023-09-30 0001873722 BBLR:NewYorkPremisisMember 2022-01-01 2022-09-30 0001873722 BBLR:PCGAdvisoryMember 2022-03-25 2022-03-25 0001873722 BBLR:BeyondMediaSEZCMember 2023-02-14 2023-02-14 0001873722 BBLR:MilestoneManagementServicesLLCMember 2023-02-23 2023-02-23 0001873722 BBLR:BeyondMediaSEZCMember 2023-02-23 2023-02-23 0001873722 BBLR:OutSideTheBoxMember 2023-05-01 2023-05-01 0001873722 BBLR:OutSideTheBoxMember 2023-08-01 2023-08-01 0001873722 BBLR:LaunchpadIRMember 2023-06-15 2023-06-15 0001873722 BBLR:WiseLawPCMember 2023-06-23 2023-06-23 0001873722 BBLR:ChetwoodMember BBLR:AmendedEmploymentAgreementMember 2023-04-01 2023-04-01 0001873722 BBLR:ChetwoodMember 2023-02-10 2023-02-10 0001873722 BBLR:ChetwoodMember BBLR:AmendedEmploymentAgreementMember 2023-04-01 0001873722 BBLR:StephenMorrisMember BBLR:AmendedEmploymentAgreementMember 2023-04-01 2023-04-01 0001873722 BBLR:StephenMorrisMember BBLR:AmendedEmploymentAgreementMember 2023-04-01 0001873722 BBLR:TimothyBurksMember BBLR:AmendedEmploymentAgreementMember 2023-04-01 2023-04-01 0001873722 BBLR:TimothyBurksMember BBLR:AmendedEmploymentAgreementMember 2023-04-01 0001873722 BBLR:PaulMorrisseyMember BBLR:AmendedEmploymentAgreementMember 2023-04-06 2023-04-06 0001873722 BBLR:PaulMorrisseyMember BBLR:AmendedEmploymentAgreementMember 2023-04-06 0001873722 BBLR:RikWillardMember BBLR:AmendedEmploymentAgreementMember 2022-05-25 2022-05-25 0001873722 BBLR:RikWillardMember BBLR:AmendedEmploymentAgreementMember us-gaap:RestrictedStockUnitsRSUMember 2022-05-25 2022-05-25 0001873722 BBLR:StevenSaundersMember BBLR:AmendedEmploymentAgreementMember 2022-05-25 2022-05-25 0001873722 BBLR:StevenSaundersMember BBLR:AmendedEmploymentAgreementMember us-gaap:RestrictedStockUnitsRSUMember 2022-05-25 2022-05-25 0001873722 BBLR:StevenSaundersMember 2023-01-01 2023-09-30 0001873722 BBLR:StevenSaundersMember 2023-02-10 0001873722 BBLR:StevenSaundersMember 2023-02-20 0001873722 BBLR:StevenSaundersMember BBLR:AugustThirtyFirstTwentyTwentyThreeMember 2023-01-01 2023-09-30 0001873722 BBLR:StevenSaundersMember 2022-05-31 2022-05-31 0001873722 BBLR:RikWillardMember 2023-01-01 2023-09-30 0001873722 BBLR:RikWillardMember 2023-02-20 0001873722 BBLR:WillardSixMonthSeveranceMember BBLR:FebruaryTwentyEightTwentyTwentyThreeUntilJulyThirtyFirstTwentyTwentyFourMember 2023-01-01 2023-09-30 0001873722 BBLR:WillardSixMonthSeveranceSecondaryMember BBLR:AugustThirtyFirstTwentyTwentyThreeUntilJanuaryThirtyFirstTwentyTwentyFourMember 2023-01-01 2023-09-30 0001873722 BBLR:RikWillardMember BBLR:SeptemberThirtyTwentyTwentyFourMember 2023-01-01 2023-09-30 0001873722 BBLR:RikWillardMember 2022-05-31 2022-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:EUR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

  Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended September 30, 2023

 

  Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from __________ to__________

 

Commission File Number: 333-260902

 

Bubblr, Inc.

(Exact name of registrant as specified in its charter)

 

Wyoming   86-2355916

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

21 West 46th Street

New York, New York 10036

(Address of principal executive offices)

 

(646) 814 7184

(Registrant’s telephone number)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.

 

  ☐ Large accelerated filer ☐ Accelerated filer
  Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

 

Securities registered pursuant to Section 12(b) of the Act: None

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS

DURING THE PRECEDING FIVE YEARS

 

Indicate by check mark whether the registrant filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court.

Yes No

 

APPLICABLE ONLY TO CORPORATE ISSUERS

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of November 14, 2023, there were 157,201,261 outstanding shares of the registrant’s Common Stock, $.01 par value.

 

 

 

 

 

 

INDEX

 

  Page
PART I – FINANCIAL INFORMATION 3
   
Item 1. Financial Statements. 3
   
Notes to Financial Statements (Unaudited) F-6
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 4
   
Item 3. Quantitative and Qualitative Disclosures about Market Risk 11
   
Item 4. Controls and Procedures 12
   
PART II – OTHER INFORMATION 13
   
Item 1. Legal Proceedings. 13
   
Item 1A. Risk Factors 13
   
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities 13
   
Item 3. Defaults Upon Senior Securities 13
   
Item 4. Mine Safety Disclosure 13
   
Item 5. Other Information. 13
   
Item 6. Exhibits 13
   
SIGNATURES 14

 

2

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Our consolidated financial statements included in this Form 10-Q are as follows:

 

  F-2 Consolidated Balance Sheets as of September 30, 2023, and December 31, 2022 (unaudited);
  F-3 Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2023, and 2022 (unaudited);
  F-4 Consolidated Statement of Stockholders’ Equity (Deficit) for the nine months ended September 30, 2023, and 2022 (unaudited);
  F-5 Consolidated Statements of Cash Flows for the nine months ended September 30, 2023, and 2022 (unaudited); and
  F-6 Notes to the Unaudited Consolidated Financial Statements.

 

These unaudited consolidated financial statements are condensed and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended September 30, 2023, are not necessarily indicative of the results that can be expected for the full year ending December 31, 2023.

 

3

 

 

BUBBLR INC.

 

INDEX TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2023

 

    Page
Consolidated Balance Sheets at September 30, 2023 and December 31, 2022 (Unaudited)   F-2
     
Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2023, and 2022 (Unaudited)   F-3
     
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the nine months ended September 30, 2023, and 2022 (Unaudited)   F-4
     
Consolidated Statements of Cash Flows for the nine months ended September 30, 2023, and 2022 (Unaudited)   F-5
     
Notes to Unaudited Consolidated Financial Statements   F-6

 

F-1

 

 

BUBBLR INC.

Consolidated Balance Sheets

September 30, 2023 and December 31, 2022

(Unaudited)

 

   September 30,   December 31, 
   2023   2022 
ASSETS          
Current Assets:          
Cash  $1,660   $32,533 
Other receivables   9,093    9,884 
Total current assets   10,753    42,417 
           
Non-current Assets:          
Property and equipment, net   39,133    47,956 
Intangible assets, net   1,190,704    1,325,995 
Total non-current assets   1,229,837    1,373,951 
TOTAL ASSETS  $1,240,590   $1,416,368 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current Liabilities:          
Accounts payable  $293,249   $141,605 
Accrued liabilities   1,316,874    50,094 
Loan payable, current   12,084    11,987 
Loan payable - related party, current   814,582    392,170 
Total current liabilities   2,436,789    595,856 
           
Non-current liabilities:          
Loan payable, non-current   3,232    10,465 
Loan payable - related party, non-current   529,545    525,291 
Warrant derivative liability   83,495    198,479 
Total non-current liabilities   616,272    734,235 
           
Total Liabilities   3,053,061    1,330,091 
           
Stockholders’ Equity (Deficit)          
Series C Convertible Preferred Stock, $0.001 par value, 2,000 authorized, 903 shares issued and outstanding   1    1 
Common stock, $0.01 par value, 3,000,000,000 shares authorized; 157,201,261 and 154,309,318 shares issued and outstanding at September 30, 2023 and December 31, 2022   1,572,013    1,543,093 
Additional paid-in capital   12,263,386    11,006,607 
Accumulated deficit   (16,069,209)   (12,875,437)
Accumulated other comprehensive income   421,338    412,013 
Total Stockholders’ Equity (Deficit)   (1,812,471)   86,277 
TOTAL LIABILITES AND STOCKHOLDERS’ EQUITY (DEFICIT)  $1,240,590   $1,416,368 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-2

 

 

BUBBLR INC.

Consolidated Statement of Operations and Comprehensive Loss

For the three and nine months ended September 30, 2023, and 2022

(Unaudited)

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Revenue  $-   $-   $-   $- 
Sales   1,151    -    1,151    - 
Gross profit   1,151    -    1,151    - 
                     
Operating Expenses                    
General and administrative  $1,016,034   $172,600   $2,211,310   $513,519 
Professional fees   13,878    160,794    178,612    2,449,350 
Sales and marketing   93,125    63,300    511,141    145,488 
Amortization and depreciation   54,331    60,234    176,840    268,688 
Research and development   59,889    53,132    151,160    167,087 
Total operating expense   1,237,257    510,060    3,229,063    3,544,132 
                     
Operating loss   (1,236,106)   (510,060)   (3,227,912)   (3,544,132)
                     
Other income (expense)                    
Interest income   29    389    142    1,243 
Interest expense   (7,704)   (102,088)   (9,450)   (547,352)
Gain (loss) on change in fair value of warrant derivative liability   117,515    133,096    114,984    384,383 
Foreign currency transaction gain (loss)   (44,937)   (127,776)   (6,520)   (289,790)
Total other income (expense)   64,903    (96,379)   99,156    (451,516)
                     
Net loss before income tax  $(1,171,203)  $(606,439)  $(3,128,756)  $(3,995,648)
Provision for income tax   -    -    -    - 
Net loss after income tax  $(1,171,203)  $(606,439)  $(3,128,756)  $(3,995,648)
                     
Other comprehensive income (loss)                    
Foreign currency translation gain (loss)   68,986    41,565    9,325    102,244 
Total other comprehensive income (loss)   68,986    41,565    9,325    102,244 
                     
Net comprehensive loss  $(1,102,217)  $(564,874)  $(3,119,431)  $(3,893,404)
                     
Net loss per common share, basic and diluted  $(0.01)  $0.00   $(0.02)  $(0.03)
                     
Weighted average number of common shares outstanding, basic and diluted   156,088,337    140,102,076    157,095,963    147,665,283 

 

F-3

 

 

BUBBLR INC.

Consolidated Statement of Changes in Stockholders’ Deficit

For the nine months ended September 30, 2023, and 2022

(Unaudited)

 

  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Paid-in

 Capital

  

Stock

Compensation

  

Accumulated

Deficit

   Comprehensive Income (Loss)  

Equity

(Deficit)

 
  

2019 Series A

Preferred Stock

  

Series B

Preferred Stock

  

Series C

Preferred Stock

  

Common Stock

  

Additional

   Deferred     

Accumulated

Other

  

Total

Stockholders’

 
  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Paid-in

 Capital

  

Stock

Compensation

  

Accumulated

Deficit

   Comprehensive Income (Loss)  

Equity

(Deficit)

 
                                                     
Balance - December 31, 2021      1   $     -        -   $    -    -   $0     140,186,096   $1,401,861   $5,478,801   $0   $(8,385,496)  $377,244   $       (1,127,590)
                                                                  
Issuance of common shares for Services - Executive Board                                 147,960    1,480    73,980                   75,460 
Issuance of common shares for Services - Consulting                                 19,250    193    8,787                   8,980 
Issuance of common shares for Equity Finance Agreement Incentive                                 793,039    7,930    371,884                   379,814 
Issuance of Series C Preferred Shares                       503    1              (1)                  - 
Dividend Series C Preferred shares                                                     (3,272)        (3,272)
Net loss                                                     (1,030,331)        (1,030,331)
Other comprehensive income   -     -     -     -     -     -                    -          13,373    13,373 
Balance -March 31, 2022   1   $-    -   $-    503   $1    141,146,345   $1,411,464   $5,933,451   $0   $(9,419,099)  $390,617   $(1,683,566)
                                                                  
Issuance of common shares for Services - Consulting                                 7,645,073    76,451    1,916,630                   1,993,081 
Issuance of common shares as deferred compensation                                 8,400,000    84,000    2,175,600    (2,259,600)             - 
Vesting of common shares issued as deferred compensation                                                94,150              94,150 
Issuance of Series C Preferred Shares                       400    0              95,768                   95,768 
Dividend Series C Preferred Shares                                                     (16,754)        (16,754)
Net loss                                                     (2,358,878)        (2,358,878)
Other comprehensive income   -     -     -     -     -     -                    -          47,306    47,306 
Balance -June 30, 2022   1   $-    -   $-    903   $1    157,191,418   $1,571,915   $10,121,449   $(2,165,450)  $(11,794,731)  $437,923   $(1,828,893)
                                                                  
Issuance of common shares for Services - Consulting                                 96,524    965    20,035                   21,000 
Issuance of common shares for loan waiver                                 345,220    3,452    68,251                   71,703 
Vesting of common shares issued as deferred compensation                                           -    94,150              94,150 
Dividend Series C Preferred Shares                                                     (22,133)        (22,133)
Repurchase and cancellation of Special 2019 Series A Preferred Stock via issuance of related party note payable   (1)                                      (60,000)                  (60,000)
Net loss                                                     (606,439)        (606,439)
Other comprehensive income   -     -     -     -     -     -                    -          41,565    41,565 
Balance -September 30, 2022   -   $-    -   $-    903   $1    157,633,162   $1,576,332   $10,149,735   $(2,071,300)  $(12,423,303)  $479,488   $(2,289,047)
                                                                  
Balance -December 31, 2022   -   $-    -   $-    903   $1    154,309,318   $1,543,093   $11,006,607   $0   $(12,875,437)  $412,013   $86,277 
                                                                  
Issuance of common shares for Services - Consulting                                 1,455,784    14,558    270,780                   285,338 
Forfiet of restricted stock units                                           (659,052)                  (659,052)
Issuance of common shares for Sseries C Preferred Shares Dividend                                 183,676    1,837    20,296                   22,133 
Dividend Series C Preferred Shares                                                     (21,672)        (21,672)
Net Loss                                                     (254,336)        (254,336)
Other comprehensive income   -     -     -     -     -     -                    -          (19,142)   (19,142)
Balance -March 31, 2023   -   $-    -   $-    903   $1    155,948,778   $1,559,488   $10,638,631    -    $(13,151,445)  $392,871   $(560,454)
                                                                  
Issuance of common shares for Services - Consulting                                 812,500    8,125    106,875                   115,000 
Issuance of common shares for Sseries C Preferred Shares Dividend                                 127,483    1,275    20,397                   21,672 
Vesting of Share Options                                           978,410                   978,410 
Dividend Series C Preferred Shares                                                     (21,672)        (21,672)
Net Loss                                                     (1,703,217)        (1,703,217)
Other comprehensive income   -     -     -     -     -     -                    -          (40,519)   (40,519)
Balance -June 30, 2023   -   $-    -   $-    903   $1    156,888,761   $1,568,888   $11,744,313    -    $(14,876,334)  $352,352   $(1,210,780)
                                                                  
Issuance of common shares for Services - Consulting                                 312,500    3,125    46,875                   50,000 
Vesting of Share Options                                           472,198                   472,198 
Dividend Series C Preferred Shares                                                     (21,672)        (21,672)
Net Loss                                                     (1,171,203)        (1,171,203)
Other comprehensive income   -     -     -     -     -     -                    -          68,986    68,986 
Balance -September 30, 2023   -   $-    -   $-    903   $1    157,201,261   $1,572,013   $12,263,386    -    $(16,069,209)  $421,338   $(1,812,471)

 

F-4

 

 

BUBBLR INC.

Consolidated Statement of Cashflows

For the nine months ended September 30, 2023 and 2022

(Unaudited)

 

   2023   2022 
   September 30, 
   2023   2022 
Cash Flows from Operating Activities:          
Net loss  $(3,128,756)  $(3,995,648)
Adjustments for:          
Net loss to net cash used in operating activities:          
Stock based compensation   450,338    2,098,521 
Stock based finance incentive   -    451,517 
Vesting of stock-based compensation   1,450,608    188,300 
Forfeit of restricted stock units   (659,052)   - 
Change in fair value of warrant derivative liability   (114,984)   (384,383)
Amortization of debt discount   6,954    52,287 
Amortization of intangible asset   167,630    258,365 
Depreciation   9,210    10,323 
Changes in operating assets and liabilities:          
Decrease in other receivables   887    6,113 
Increase in accrued liabilities   216,666    36,642 
Increase (decrease) in accounts payable   1,187,896    (85,900)
Net cash used in operating activities   (412,603)   (1,363,863)
           
Cash flows from investing activities          
Proceeds from repayment of advances receivable   -    1,231 
Purchase of intangible assets   (21,935)   (19,513)
Net cash used in investing activities   (21,935)   (18,282)
           
Cash flows from financing activities          
Payment of dividend   -    (20,026)
Proceeds from loans payable   -    15,000 
Repayment of loans payable   (7,467)   (22,595)
Repayment of loans payable - related party   (18,228)   (77,940)
Proceeds from loans payable - related party   408,665    498,197 
Net proceeds from issuance of Series C Preferred stock   -    789,000 
Net cash provided by financing activities   382,970    1,181,636 
           
Effects of exchange rate changes on cash   20,695    292,322 
           
Net Change in Cash   (30,873)   91,813 
Cash - Beginning of Period   32,533    62,967 
Cash - End of Period  $1,660   $154,780 
           
Supplemental information:          
Cash paid for interest  $12,921   $6,963 
Cash paid for taxes  $-   $- 
           
Non-cash investing and financing activities          
Common stock issued in satisfaction of dividend payable  $43,805   $22,133 
Repurchase and cancellation of Special 2019 Series A Preferred Stock via issuance of related party note payable  $-   $60,000 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

F-5

 

 

BUBBLR INC.

Notes to the Unaudited Consolidated Financial Statements

September 30, 2023, and 2022

 

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY

 

Organization and Operations

 

On March 26, 2020, Bubblr Holdings Ltd. (a UK company formed on February 18, 2016) merged into U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation formed on October 22, 2019, and became a 100% subsidiary of UWRL. On March 30, 2021, the Company’s corporate name was changed to Bubblr, Inc. (“the Company”).

 

Bubblr, Inc. is a Mobile Application software company that is currently developing its disruptive Internet Search Mechanism and seeking license opportunities for a next-generation solution designed to create an alternative economic model.

 

Going Concern Matters

 

The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $3,119,431 during the nine months ended September 30, 2023, and has an accumulated deficit of $16,069,209 as of September 30, 2023. In addition, current liabilities exceed current assets by $2,426,036 as of September 30, 2023.

 

Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors.

 

There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings, and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings, and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations.

 

Due to uncertainties related to these matters, there exists substantial doubt about the ability of the Company to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation.

 

F-6

 

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.

 

Convertible Financial Instruments

 

The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.

 

Fair Value of Financial Instruments

 

The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below:

 

Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data.

 

Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

 

The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the year ended December 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments that are adjusted to fair market value on reporting dates. At September 30, 2023 and December 31, 2022 the warrant liabilities balances were $83,495 and $198,479 respectively. There were no changes in the fair value hierarchy leveling during the nine months ended September 30, 2023.

 

Stock Based Compensation

 

We follow ASC Topic 718, Compensation–Stock Compensation, which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expense in the financial statements based on the stock awards’ fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). Restricted stock units (“RSUs”) issued as compensation in accordance with the Company’s 2022 Equity Incentive Plan are deemed to be unissued until fully vested. RSU compensation is recognized as expense over the vesting period. Upon repurchase of the award any unrecognized compensation, net of cash payments, is expensed immediately. Awards forfeited due to unfulfillment of obligations, such as termination of employment prior to the award being fully vested, for no cash or other consideration, are not recognized as an expense and any previously recognized costs are reversed in the period of forfeiture.

 

Employees – We account for share-based compensation under the fair value method which requires all such compensation to employees, including the grant of employee stock options, to be calculated based on its fair value at the measurement date (generally the grant date), and recognized in the consolidated statement of operations over the requisite service period.

 

F-7

 

 

Nonemployees - Under the requirements of the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), we account for share-based compensation to non-employees under the fair value method which requires all such compensation to be calculated based on the fair value at the measurement date (generally the grant date), and recognized in the statement of operations over the requisite service period.

 

Common Stock Purchase Warrants and Derivative Financial Instruments

 

Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

 

Basic and Diluted Net Loss per Common Share

 

Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses.

 

For the nine months ended September 30, 2023, and 2022, the following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive.

   2023   2022 
   September 30, 
   2023   2022 
   (Shares)   (Shares) 
Series C Preferred Stock   3,384,135    3,384,135 
Warrants   2,358,101    2,358,101 
Convertible Notes   -    2,037,834 
Total   5,742,236    7,780,070 

 

Foreign Currency Translations

 

The functional currency of the Company’s international subsidiaries is generally their local currency of Great British Pounds (GBP). Local currency assets and liabilities are translated at the exchange rates on the balance sheet date, and local currency revenues and expenses are translated at weighted average exchange rates during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income.

 

   2023   2022   2022 
   September 30,   December 31, 
   2023   2022   2022 
Period-end GBP£: U.S.$ exchange rate   1.2199    1.1171    1.2101 
Weighted average GBP£: U.S.$ exchange rate   1.2447    1.2661    1.2430 

 

Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Losses on foreign exchange transactions totaling $6,250 and $289,790 were recognized during the nine months ended September 30, 2023, and 2022, respectively.

 

F-8

 

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

As of September 30, 2023, and December 31, 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions.

 

UK Taxes

 

We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns.

 

UK Tax Risk

 

Companies that are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”).

 

In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”), which is charged at 25% of any “taxable diverted profit.”. The DPT has had an effect since April 1, 2015, and may apply in circumstances including (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE).

 

However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax.

 

Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and, as a result, a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr.

 

Recent Accounting Pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

 

F-9

 

 

Reclassifications

 

Certain accounts have been reclassified in prior periods to conform to current period presentation. Compensation expense that was previously reported separately has been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented.

 

NOTE 3 – OTHER RECEIVABLES

 

As of September 30, 2023, and December 31, 2022, accounts receivable consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
         
Deposit  $200   $200 
UK VAT Receivable   8,893    9,684 
 Other receivables  $9,093   $9,884 

 

NOTE 4 - PROPERTY AND EQUIPMENT

 

As of September 30, 2023, and December 31, 2022, property and equipment consisted of the following:

 

  

Motor

Vehicles

  

Computer

Equipment

  

Office

Equipment

   Total 
Cost                    
At December 31, 2022  $56,875   $28,179   $563   $85,617 
Additions   -    -    -    - 
Effects of currency translation   460    228    4    692 
At September 30, 2023   57,335    28,407    567    86,309 
                     
Less accumulated depreciation                    
At December 31, 2022  $18,659   $18,636   $366   $37,661 
Depreciation expense   4,576    4,550    84    9,210 
Effects of currency translation   151    152    2    305 
At September 30, 2023   23,386    23,338    452    47,176 
                     
Net book value                    
At September 30, 2023   33,949    5,069    115    39,133 
At December 31, 2022  $38,216   $9,543   $197   $47,956 

 

During the nine months ended September 30, 2023, and 2022, the Company recorded depreciation expenses of $9,210 and $10,323, respectively. There were no purchases, impairment, or disposals of property and equipment.

 

NOTE 5 - INTANGIBLE ASSETS

 

A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa, New Zealand, Canada, and Australia. The patent is pending in the European Union, and the United Kingdom.

 

Patents on Contextual Enveloping of Dynamic Hypertext Links and Real-Time Data Processing are pending in the United States

 

Patents are reported at cost, less accumulated amortization, and accumulated impairment loss. Costs include expenditure that is directly attributable to the acquisition of the asset. Once a patent provides economic benefit to the Company, amortization is provided on a straight-line basis on all patents over their expected useful lives of 20 years.

 

F-10

 

 

Intellectual Property

 

Intellectual Property capitalizes the Company’s qualifying internal research and developments costs. Intellectual property is amortized over its useful life of 7 years and reported at cost less accumulated amortization and accumulated impairment loss.

 

Trademarks

 

The Company has the following trademarks.

 

Mark   Category   Proprietor   Country   Class(es)   Status   Reg. Date.   File No.
CITIZENS JOURNALIST   Words   Bubblr Limited   European Union   9 38   REGISTERED   16-Nov-2019   206382.EM.01
CITIZENS JOURNALIST   Word   Bubblr Limited   United Kingdom   9 38   REGISTERED   05-Jul-2019   206382.GB.01
CITIZENS JOURNALIST   Words   Bubblr Limited   United Kingdom   9 38   REGISTERED   16-Nov-2019   206382.GB.02
CITIZENS JOURNALIST   Word   Bubblr Limited   United States   9 38 41 42   REGD-DEC USE   08-Feb-2022   206382.US.01
  Words and Color Device   Bubblr Limited   European Union   9 38   REGISTERED   16-Nov-2019   206383.EM.01
  Series of Logos   Bubblr Limited   United Kingdom   9 38   REGISTERED   05-Jul-2019   206383.GB.01
  Words and Color Device   Bubblr Limited   United Kingdom   9 38   REGISTERED   16-Nov-2019   206383.GB.02
  Words and Device   Bubblr Limited   United States   9 38 41 42   ACCEPTED       206383.US.01
BAU NOT OK/BAU Not OK   Series of Marks   Bubblr Limited   United Kingdom   9 38   REGISTERED   11-Oct-2019   208674.GB.01
NEWZMINE/NewzMine   Series of Marks   Bubblr Limited   United Kingdom   9 38 42   REGISTERED   25-Dec-2020   227753.GB.01

 

 

The Company capitalizes trademark costs where the likelihood of acceptance is expected. Each trademark has been determined to have an infinite useful life and is assessed each reporting period for impairment. If there has been a reduction in the value of the trademark or if the trademark is not successfully registered, the assets will be impaired and charged to expense in the period of impairment.

 

As of September 30, 2023, and December 31, 2022, trademarks consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Trademarks:          
NewzMineTM  $11,494   $9,920 
Citizens Journalist™   25,367    25,367 
Effects of currency translation   (3,204)   (3,461)
   $33,657   $31,826 

 

As of September 30, 2023, and December 31, 2022, intangible assets consisted of the following:

 

   Patents   Trademarks  

Intellectual

Property

  

Capitalized

Acquisition

Costs

   Total 
Cost                         
At December 31, 2022  $168,300   $31,826   $2,764,198   $45,745   $3,010,069 
Additions   20,361    1,574    -    -    21,935 
Effects of currency translation   1,362    257    22,388    -    24,007 
At September 30, 2023  $190,023   $33,657   $2,786,586   $45,745   $3,056,011 
                          
Less accumulated amortization                         
At December 31, 2022  $4,947   $-   $1,674,551   $4,576   $1,684,074 
Amortization expense   37,272    -    128,642    1,716    167,630 
Effects of currency translation   40    -    13,563    -    13,603 
At September 30, 2023  $42,259   $-   $1,816,756   $6,292   $1,865,307 
                          
Net book value                         
At September 30, 2023  $147,764   $33,657   $969,830   $39,453   $1,190,704 
At December 31, 2022  $163,353   $31,826   $1,089,647   $41,169   $1,325,995 

 

F-11

 

 

During the nine months ended September 30, 2023, and 2022, the Company purchased $21,935 and $19,513 in intangible assets and recorded amortization expenses of $167,630 and $258,365, respectively. During the nine months ended September 30, 2023, and 2022, impairment of $0 and $0 was recorded. Based on the carrying value of definite-lived intangible assets as of September 30, 2023, we estimate our amortization expense for the next five years will be as follows:

 

           Capitalized     
       Intellectual   Acquisition     
Nine months ended September 30,  Patents   Property   Costs   Total 
Three months 2023  $1,847   $34,637   $572   $37,056 
2024   7,388    138,547    2,888    148,823 
2025   7,388    138,547    2,888    148,823 
2026   7,388    138,547    2,888    148,823 
2027   7,388    138,547    2,888    148,823 
2028   7,388    138,547    2,888    148,823 
Thereafter   108,977    242,458    27,441    378,876 
Finite-Lived Intangible Assets, Net  $147,764   $969,830   $39,453   $1,157,047 

 

NOTE 6 – ACCRUED LIABILITIES

 

As of September 30, 2023, and December 31, 2022, accrued liabilities consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Accruals  $50,256   $- 
Accrued interest   -    3,143 
Directors Fees   143,750    - 
Dividends payable   43,344    22,133 
Settlement payable   154,185    - 
Wages and salaries   925,339    24,818 
Total Accrued liabilities  $1,316,874   $50,094 

 

NOTE 7 – LOAN PAYABLE

 

On February 4, 2022, the Company issued a promissory note for the principal sum of $20,000 to White Lion Capital, LLC, a Nevada company. The note had an original issue discount of 25%. The principal of $20,000 was repaid in full on April 26, 2022. The net proceeds received by the Company totaled $15,000, and the $5,000 debt discount was amortized to interest expense during the period the loan was outstanding.

 

In November 2019, the Company purchased a vehicle under a capital finance arrangement. The term of this loan is 5 years, and the annual interest rate is 6.90%. At September 30, 2023, and December 31, 2022, loan payable obligations included in current liabilities were $ and $11,987, respectively, and loan payable obligations included in long-term liabilities were $0 and $10,465, respectively.

 

During the nine months ended September 30, 2023, and 2022, the Company made $7,467 and $7,595, respectively, in loan payments.

 

F-12

 

 

At September 30, 2023, future minimum payments under the loan are as follows:

 

   Total 
2023 (three months remaining in 2023)  $2,489 
2024   9,955 
Total   12,444 
Less: Imputed interest   2,872 
Loan payable   15,316 
      
Loan payable – current   12,084 
Loan payable - non-current  $3,232 

 

NOTE 8 - RELATED PARTY TRANSACTIONS

 

Loans from Related Parties

 

The Company had received a loan from a minority shareholder of $19,709 in February 2022 that bore interest at the rate of 20% per annum. The principal of $18,228, plus accrued interest of $3,646, totaling $21,874 was repaid on February 15, 2023. The related party loan of $81,162 was borrowed in Q4 2021, which bore no interest, and was repaid in full by April 30, 2022.

 

In the nine months to September 30, 2023, the Company received a loan of $27,67222,700) from an executive of the Company. The Loan had an original issue discount of $6,954 5,700). The net proceeds received by the Company totaled $20,73817,000), and the $6,9545,700) debt discount was amortized to interest expense during the period the loan was outstanding. The loan principal is due to be repaid on October 6, 2023.

 

Activity on this loan to arrive at September 30, 2023, and December 31, 2022, balances is as follows:

   September 30,   December 31, 
   2023   2022 
Beginning Balance  $18,152   $81,162 
Effects of currency translation   76    (4,779)
Loan Payable   18,228    76,383 
           
Addition   27,692    19,709 
Repayment   (18,228)   (77,940)
Ending Balance  $27,692   $18,152 

 

During the nine months ended September 30, 2023, and 2022, the Company received proceeds on these loans of $20,738ok directors fee and $19,709, respectively, made repayments of $18,228 and $79,940, respectively, and accrued interest of $0 and $443, respectively. The Loans from related parties were received in GBP, and any difference deduced is due to fluctuation in the exchange rate.

 

The Company has loans from our founder, Stephen Morris, with a balance of $1,316,435 and $899,309 at September 30, 2023 and December 31, 2022, respectively as follows:

 

Loan 1.

 

The loan is non-interest-bearing and repayable on demand.

 

On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have a maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment.

 

In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD, the Company shall pay to Mr. Morris an amount equal to $140,289 (£115,000) as an installment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date

 

F-13

 

 

On September 6, 2022, the Company entered into a second amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to add $60,00052,088) to the principal of the loan in exchange for Mr. Morris canceling his Special 2019 Series A Preferred Stock, which had super-voting rights.

 

On December 20, 2022, the Company entered into a third amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to reduce the outstanding principal amount of the loan by $71,54059,543) in exchange for the Company assigning advances receivables of $71,54059,543) whereon Mr. Morris is entitled to amounts received pursuant to such receivables and will bear the risk of non-payment with respect to such receivables. After this assignment, the Company will have no right to receive any amounts collected with respect to such receivables and will have no liability for non-payment of the receivables or any costs of collections.

 

In aggregate, the Company received $387,927 and $0 proceeds and made repayments of $0 and $0 during the nine months ended September 30, 2023, and 2022, respectively, on the loans with Mr. Morris.

 

Loan 2.

 

On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for $501,049434,060). The Loan Agreement is unsecured, carries no interest, is non-convertible, and is due upon maturity, which is three years after the date of the agreement.

 

Activity on this loan to arrive at September 30, 2023, and December 31, 2022, balances is as follows:

 

  

Nine Months Ended

September 30,

  

Year Ended

December 31,

 
   2023   2022 
Beginning balance current  $374,018    428,117 
Effects of currency translation   3,029    (42,619)
Loan Payable   377,047    385,558 
Additions   387,927      
Conversion from preferred stock   -    60,000 
Assignment of advances receivable   21,916    (71,540)
Ending balance – Current  $786,890   $374,018 
           
Beginning balance non-current  $525,291   $- 
Additions   -    501,049 
Effects of currency translation   4,254    24,242 
Ending balance non-current  $529,545    525,291 
           
Ending balance current and non-current  $1,316,435   $899,309 

 

NOTE 9 - WARRANT LIABILITY

 

The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 10) for derivative accounting consideration under ASC 815, Derivatives and Hedging, and determined that the instruments should be classified as a liability due to reset provisions and variability in exercise price resulting in there being no fixed value or explicit limit to the number of shares to be delivered upon exercise. ASC 815 requires us to assess the fair market value of the derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item.

 

F-14

 

 

The Company determined our warrant liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities and used the Black Scholes pricing model to calculate the fair value as of September 30, 2023. The Black Scholes model requires nine basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each warrant is estimated using the Black-Scholes valuation model.

 

For the period ended September 30, 2023, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows:

 

   Nine Months Ended 
   September 30, 
   2023 
Expected term   1.71 - 2.50 years 
Expected average volatility   177 - 220%
Expected dividend yield   8.33%
Risk-free interest rate   1.505.46%

 

The following table summarizes the changes in the warrant liabilities during the period ended September 30, 2023, and December 31, 2022:

 

Fair Value Measurements Using Significant Unobservable Inputs (Level 3) 
      
Addition of new warrants  $721,275 
Additional day-one loss   (28,043)
Change in fair value of warrant liability   (494,753)
Warrant liability as of December 31, 2022  $198,479 
      
Addition of new warrants  $- 
Additional day-one loss   - 
Change in fair value of warrant liability   (114,984)
Warrant liability as of September 30, 2023  $83,495 

 

NOTE 10 - STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

The Company has authorized 25,000,000 preferred shares with a par value of $0.001 per share. The Board of Directors is authorized to divide the authorized shares of Preferred Stock into one or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes.

 

Series C Convertible Preferred Stock

 

On March 4, 2022, the Company filed a Certificate of Designation with the Wyoming Secretary of State, which established 2,000 shares of the Company’s Series C Convertible Preferred Stock, with a Stated Value of $1,200 per share.

 

The Company has the right to redeem the Series C Convertible Preferred Stock in accordance with the following schedule:

 

  The Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and
     
  The Company shall pay 8% per annum dividend on the Series C Convertible Preferred Stock. Dividends shall be paid quarterly, and at the Company’s discretion, in cash or Series C Convertible Preferred Stock. Dividends shall be deemed to accrue from the date of issuance of the Series C Convertible Preferred Stock whether or not earned or declared and whether or not there are profits, surplus, or other funds of the Company legally available for the payment of dividends.

 

F-15

 

 

The Series C Convertible Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations (as set forth in the Certificate of Designation).

 

Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $1,200 of such share by the Conversion Price of $0.3202.

 

On March 4, 2022, the Company entered into a Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), whereby GHS agreed to purchase, in tranches, up to $700,000 of the Company’s Series C Convertible Preferred Stock in exchange for 700 shares of Series C Convertible Preferred Stock.

 

On March 4, 2022, the Company issued to GHS the first tranche of 300 shares of Series C Convertible Preferred Stock, as well as commitment shares of 35 shares of Series C Convertible Preferred Stock and 941,599 warrant shares (the “GHS Warrant”). Warrant shares represent 75% of the number of shares of common stock issuable upon conversion of the Series C Convertible Preferred Stock (the “GHS Warrant Shares”). The Company has agreed to register the shares of common stock issuable pursuant to the conversion of the Series C Convertible Preferred Stock and the GHS Warrant Shares.

 

GHS delivered gross proceeds of $266,000 to the Company (excluded were legal fees and a transaction fee charged by Spartan Capital).

 

On March 9, 2022, the Company entered a Securities Purchase Agreement with Proactive Capital Partners LP (“Proactive”), whereby Proactive agreed to purchase 160 shares of Series C Preferred Stock. .

 

The Company agreed to issue Proactive commitment shares of 8 shares of Series C Convertible Preferred Stock and 472,205 warrant shares (the “Warrant”). Warrant shares represent 75% of the number of shares of common stock issuable upon conversion of the Series C Convertible Preferred Stock (the “Warrant Shares”). The Company has agreed to register the shares of common stock issuable pursuant to the conversion of the Series C Convertible Preferred Stock and the Warrant Shares.

 

On March 9, 2022, the Company issued 168 shares of Series C Convertible Preferred stock to Proactive Capital Partners LP as per the Securities Purchase Agreement. Proactive delivered gross proceeds of $290,000 to the Company (excluded were legal fees).

 

On April 24, 2022, the Company issued the second tranche of 200 shares of Series C Convertible Preferred Stock and 562,149 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. GHS delivered gross proceeds of $184,000 to the Company (excluded were legal fees and a transaction fee charged by Spartan Capital).

 

On May 25, 2022, the Company issued the third tranche of 100 shares of Series C Convertible Preferred Stock and 281,074 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. GHS delivered gross proceeds of $92,000 to the Company (excluded were legal fees and a transaction fee charged by Spartan Capital).

 

On September 24, 2022, the Company issued the fourth tranche of 100 shares of Series C Convertible Preferred Stock and 281,074 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. GHS delivered gross proceeds of $92,000 to the Company (excluded were legal fees and a transaction fee charged by Spartan Capital).

 

F-16

 

 

On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for £434,060 (US$550,468 at September 30, 2023). In order to enter into the new loan, GHS Investments, LLC agreed to waive a prohibition on borrowing over $200,000 found in our Certificate of Designation for the Series C Preferred Stock, in exchange for our company issuing 345,220 shares of common stock: 281,000 shares of common stock to GHS and 64,220 shares of common stock to Proactive. The resulting common shares were valued at $71,703, recorded as interest expense.

 

As a result of the above transactions, the Company received total net proceeds of $789,000, of which $721,275 has been allocated to the warrants and Series C Preferred Stock based on the warrants’ fair market values on each contract date, with the residual loss of $28,043 allocated to day-one loss on warrant liability associated with the March 2022 issuances, and excess proceeds of $95,768 allocated to the Series C Preferred Stock associated with the April, May, and September 2022 issuances.

 

As at September 30, 2023 and December 31, 2022, the Company had 903 shares of Series C Preferred Stock issued and outstanding.

 

Common Stock

 

The Company has authorized 3,000,000,000 common shares with a par value of $0.01 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

 

During the nine months ended September 30, 2022, the Company issued the following unregistered securities:

 

  147,960 shares for Executive Board Chair services valued at $75,460.
  67,079 shares for Investor Relations services valued at $22,980.
  7,597,244 shares for Consultancy services valued at $1,979,082.
  587,039 shares as commitment shares under the Equity Financing Agreement with GHS.
  206,000 shares to White Lion Capital, LLC as a result of a Termination and Release Agreement.
  903 shares of Series C Preferred Stock and 75% warrant coverage in connection with Securities Purchase Agreements with GHS and Proactive

 

During the nine months ended September 30, 2023, the Company issued the following unregistered securities:

 

  625,000 shares for Consultancy services valued at $100,000.
  500,000 shares for Professional services valued at $65,000.
  311,159 shares for dividend due of Series C Preferred Stock valued at $43,805.
  1,455,784 shares for Investor Relations services valued at $285,338.

 

As at September 30, 2023, and December 31, 2022, the Company had 157,201,261 and 154,309,318 shares of common stock issued and outstanding, respectively.

 

The above securities were issued in reliance on the exemption from registration provided by Section 4.(a)(2) of the Securities Act of 1933, as amended, and/or in reliance on the exception from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended. 

 

Warrants

 

The Company identified conversion features embedded within warrants issued during the nine months ended September 30, 2022. The Company has determined that the conversion feature of the Warrants represents an embedded derivative since the conversion price includes a reset provision which could cause adjustments in redemption value and the number of shares issued upon exercise (see Note 9 - Warrant Liability).

 

A summary of activity during the nine-month period ended September 30, 2023, follows:

 

   Warrants Outstanding   Weighted Average 
   Number of   Weighted Average  

Remaining life

 
   Warrants   Exercise Price   (years) 
             
Outstanding, December 31, 2022   2,538,101   $0.32    4.27 
Granted   -    -    - 
Exercised   -    -    - 
Forfeited/canceled   -    -    - 
Outstanding, September 30, 2023   2,538,101   $0.32    3.52 
                
Exercisable Warrants, September 30, 2023   2,538,101   $0.32    3.52 

 

The following table summarizes information relating to outstanding and exercisable warrants as of September 30, 2023:

 

Warrants Outstanding   Warrants Exercisable 

Number of

Warrants

  

Weighted

Average

Remaining

Contractual

life (in years)

  

Weighted

Average

Exercise Price

  

Number of

Shares

  

Weighted Average

Exercise Price

 
 941,599    3.43   $0.34    941,599   $0.34 
 472,205    3.44    0.34    472,205    0.34 
 562,149    3.57    0.35    562,149    0.35 
 281,074    3.65    0.22    281,074    0.22 
 281,074    3.74    0.22    281,074    0.22 
 2,538,101    3.52   $0.32    2,538,101   $0.32 

 

As at September 30, 2023, the intrinsic value of the warrants is $0, as the price of the Company’s stock was below the warrant exercise price.

 

2022 Equity Incentive Plan

 

Restricted Stock Units

 

On May 25, 2022, our board of directors and majority shareholders approved the adoption of the Bubblr, Inc. 2022 Equity Incentive Plan (the “2022 Equity Incentive Plan”) and, unless earlier terminated, will continue until May 25, 2032. A total of 28,400,000 shares of common stock may be issued under the 2022 Equity Incentive Plan. The 2022 Equity Incentive Plan aims to foster and promote our long-term financial success and increase stockholder value by motivating performance through incentive compensation. The 2022 Equity Incentive Plan is intended to encourage participants to acquire and maintain ownership interests in our company and to attract and retain the services of talented individuals upon whose judgment and special efforts the successful conduct of our business is largely dependent.

 

If the employee is terminated for cause, the employee will forfeit the Restricted Stock Units (“RSUs”) awarded to date.

 

During the year ended December 31, 2022, the Company issued, pursuant to the 2022 Equity Incentive Plan, a total of 8,400,000 RSUs to two Company executives pursuant to their employment agreements. (See Note 11 - Commitments and Contingencies) 4,200,000 shares of performance-based stock compensation were scheduled to vest on each September 1, 2023, and September 1, 2024, respectively. The Company had elected to treat the award as a single award of 8,400,000 shares that vests ratably over the vesting period.

 

The RSUs were valued at $2,259,600, based on the market price of the Company’s common stock on the respective grant dates of the agreements, which was $0.269 per share, and were to be recognized as compensation expense over their two-year vesting period on a straight-line basis. During the year ended December 31, 2022, the Company recorded stock-based compensation of $659,052 and had unrecognized stock compensation of $1,600,548 as of December 31, 2022.

 

On January 31, 2023 (the “Termination Date”), the award of 8,400,000 RSUs was forfeited by the executives upon their termination of employment. Pursuant to ASC-718-10-30-12, no compensation cost is recognized for instruments that employees forfeit for no cash or other consideration because a service or performance condition is not satisfied. Further, the value of instruments for which the requisite service is not rendered before the award is fully vested is not recognized as an expense, and any previously recognized costs are reversed upon forfeiture. As a result, the remaining unvested stock compensation of $1,600,548 was not recognized, and the prior year recognition of $659,052 in compensation was reversed on the Termination Date.

 

F-17

 

 

Stock Options

 

On April 1, 2023, the Company granted options for purchasing our Common stock to certain employees and non-employees as consideration for services rendered. The terms of the stock option grants are determined by our Board of Directors consistent with our 2022 Equity Incentive Plan, which the Board adopted on May 22, 2022. Our stock option grant general policy is options vest 40% on the Grant Date, which is 90 days after commencement of service (typically the hire date), and the remaining vest monthly over two years and has a maximum term of ten years. Two executives with long-term service over two years and nine months were 100% vested on the Grant Date.

 

The Company determined our option liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities and used the Black Scholes pricing model to calculate the fair value as of the Grant Date of the options. The Black Scholes model requires nine basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each warrant is estimated using the Black-Scholes valuation model.

 

For the period ended September 30, 2023, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows:

 

   Nine Months Ended 
   September 30, 
   2023 
Expected term   5.005.00 years 
Expected average volatility   195 - 199%
Expected dividend yield   0%
Risk-free interest rate   3.734.49%

 

The following summarizes the stock options activity for the nine months ended September 30, 2023:

 

   Options    Weighted-Average 
   Outstanding   Exercise Price 
Balance as of December 31, 2022   -   $- 
Grants   14,400,000    0.16 
Exercised   -    - 
Cancelled   -    - 
Balance as of September 30, 2023   14,400,000   $0.16 

 

The following summarizes certain information about stock options vested and expected to vest as of September 30, 2023:

 

Options Outstanding   Options Exercisable 

Number of

Options

  

Weighted

Average

Remaining

Contractual

life (in years)

  

Weighted

Average

Exercise Price

  

Number of

Shares

  

Weighted Average

Exercise Price

 
 3,360,000    2.22   $0.04    3,360,000   $0.069 
 960,000    0.63    0.01    960,000    0.018 
 3,360,000    2.22    0.04    1,764,000    0.031 
 4,800,000    3.17    0.05    2,160,000    0.032 
 1,920,000    1.27    0.02    864,000    0.013 
 14,400,000    9.51   $0.16    9,108,000    0.16 

 

F-18

 

 

As of September 30, 2023, and December 2022, there were $735,662 and $0, respectively, of total unrecognized compensation costs related to non-vested share-based compensation arrangements, which we expect to recognize within the next 21 months.

 

Equity Financing Agreements

 

On February 1, 2022, Bubblr, Inc. entered into a Stock Purchase Agreement (the “SPA”) and Registration Rights Agreement with White Lion Capital LLC (“WLC”). Pursuant to the SPA, the Company had the right, but not the obligation, to cause WLC to purchase up to $10 million of our common stock during the period beginning on February 1, 2022, and ending on the earlier of (i) the date on which the WLC had purchased $10 million of our common stock pursuant to the SPA, or (ii) December 31, 2022.

 

In consideration for entering into the SPA, on February 1, 2022, the Company issued 103,000 shares of common stock to WLC valued at $93,792.

 

On March 22, 2022, the Company entered into a Termination and Release Agreement with WLC to extinguish the SPA and Registration Rights Agreement in exchange for issuing 103,000 shares of common stock. The stock was issued on March 22, 2022, and was valued at $51,500.

 

On March 4, 2022, the Company entered into an Equity Financing Agreement (“EFA”) and Registration Rights Agreement with GHS Investments LLC (“GHS”). Under the terms of the EFA, GHS agreed to provide the Company with up to $15 million upon effectiveness of a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission.

 

The registration statement on Form S-1 was effective as of September 24, 2022. During the year ended December 31, 2022, and through September 30, 2023, GHS subsequently provided $0 under the EFA.

 

In consideration for entering the EFA, on March 4, 2022, the Company issued 587,039 shares of common stock to GHS valued at $234,522.

 

NOTE 11 - COMMITMENTS AND CONTINGENCIES

 

Premises

 

During the nine months ended September 30, 2023, and 2022, the Company paid $473 and $5,345 for its rented premises in Dunfermline, Scotland. The 12-month lease was not renewed in March 2021, and they vacated the premises on July 14, 2022. The Company currently rents virtual office space on a month-by-month rolling contract at a monthly rate of $100. This lease is exempt from ASC 842 lease accounting due to its short term.

 

During the nine months ended September 30, 2023, and 2022, the Company paid $1,800 and $1,800 for use of premises in New York, New York. The 12-month agreement was signed in August 2021 for twelve months, after which it became a rolling monthly contract at a monthly rate of $200 and is exempt from ASC 842 lease accounting due to its short term.

 

On March 25, 2022, the Company entered into a service agreement with PCG Advisory, Inc. The term was nine months, commencing April 1, 2022. PCG Advisory, Inc. received cash of $7,000, plus $7,000 monthly stock compensation. The number of shares was to be determined based on the closing price on the last trading day of the previous month. The contract was terminated effective February 28, 2023.

 

F-19

 

 

Service Contracts

 

On February 14, 2023, the Company entered into a service agreement with Beyond Media SEZC. The term is twelve months, commencing February 14, 2023. Beyond Media will receive cash of $7,000 per month and has received 1,000,000 shares of common stock as stock compensation valued at $180,000.

 

On February 23, 2023, the Company entered into a service agreement with Milestone Management Services, LLC. The term is six months, commencing February 23, 2023. Milestone Media Services, LLC received 325,000 shares of common stock as compensation valued at $84,338. The service agreement was terminated on August 23, 2023.

 

On May 1, 2023, the Company entered into a service agreement with Outside-the-Box. The term is six months, commencing May 1, 2023. Outside-the-Box is entitled to 625,000 shares of common stock valued at $100,000 in consideration for entrance into the agreement. 312,500 shares of common stock were issued May 1, 2023, with the balance of 312,500 issued on August 1, 2023.

 

On June 15, 2023, the Company entered into a service agreement with Launchpad IR. The term is six months, commencing September 15, 2023. Launchpad IR will receive compensation of $3,000 per month.

 

On June 23, 2023, the Company entered into a service agreement with Wise Law P.C. Wise Law P.C. received 500,000 shares of common stock as compensation valued at $65,000.

 

Employment Agreements

 

David Chetwood

 

On April 1, 2023, our board of directors approved amended and restated employment agreement effective February 10, 2023, in favor of Chief Financial Officer, David Chetwood.

 

The amended employment agreement with Mr. Chetwood provides that we will compensate him with a yearly salary of $450,000, with payments reduced to $180,000 per annum until securing $5 million in debt or financing. As per the employment agreement, an accrual is made for any unpaid portion of the compensation, which comprises the reduced amount if not paid in the month due and the additional amount due upon securing finance or on termination of the employment agreement. We also agreed to grant Mr. Chetwood the option to purchase 3,600,000 shares of common stock at $0.1625 per share, with 40% vesting after 90 days of service and 60% vesting monthly over the following two years. He is also entitled to health and vacation benefits and, after 90 days of employment, a six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Chetwood agreed to a two-year non-solicit restrictive covenant.

 

Stephen Morris

 

On April 1, 2023, our board of directors approved amended and restated employment agreement in favor of our Chief Technical Officer, Stephen Morris.

 

The amended employment agreement with Mr. Morris provides that we will compensate him with a yearly salary of $450,000, with payments reduced to $180,000 per annum until securing $5 million in debt or financing. As per the employment agreement, an accrual is made for any unpaid portion of the compensation which comprises the reduced amount if not paid in the month due and the additional amount due upon securing finance or on termination of the employment agreement. We also agreed to grant Mr. Morris an option to purchase 3,360,000 shares of common stock at $0.187 per share, fully vested. He is also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Morris agreed to a two-year non-solicit restrictive covenant.

 

Timothy Burks

 

On April 1, 2023, our board of directors approved an employment agreement and stock option grant in favor of our Chief Executive Officer, Mr. Burks. The employment agreement with Mr. Burks provides that we will compensate him with a yearly salary of $600,000, with payment reduced to $240,000 per annum upon securing $5 million in debt or financing. As per the employment agreement an accrual is made for any unpaid portion of the compensation which comprises the reduced amount if not paid in the month due and the additional amount due upon securing finance or on termination of the employment agreement. We also agreed to grant Mr. Burks the option to purchase 4,800,000 shares of common stock, at $0.1353 per share, with 40% vesting after 90 days of service and 60% vesting monthly over the following two years. He is also entitled to health and vacation benefits and, after 90 days of employment, a six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Burks agreed to a two-year non-solicit restrictive covenant.

 

F-20

 

 

Paul Morrissey

 

On April 6, 2023, our board of directors approved a Non-Executive Board Agreement and Stock Option Grant in favor of Mr. Morrissey. The agreement with Mr. Morrissey provides that we will compensate him with a yearly fee of $300,000, paid monthly but reduced to $120,000 until securing $5 million in debt or financing. As per the non-executive board agreement, an accrual is made for any unpaid portion of the compensation which comprises the reduced amount if not paid in the month due and the additional amount due upon securing finance or on termination of the employment agreement. We also agreed to grant Mr. Morrissey the option to purchase 1,920,000 shares of common stock, at $0.1353 per share, with 40% vesting after 90 days of service and 60% vesting monthly over the following two years. He is also entitled toa six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Morrissey agreed to a two-year non-solicit restrictive covenant.

 

Steven Saunders & Rik Willard

 

On May 31, 2022, our board of directors approved amended and restated employment agreements in favor of our then-Chief Executive Officer, Rik Willard, and our then-Chief Commercial Officer, Steven Saunders.

 

The employment agreement with Mr. Willard was amended as follows. In addition to his cash compensation, the Company agreed to further compensate Mr. Willard in accordance with our May 25, 2022, Equity Incentive Plan with 5,400,000 restricted stock units, which vest 2,700,000 annually over a period of two years. He was also entitled to health and vacation benefits and nine-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He was also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Willard agreed to a two-year non-solicit restrictive covenant. The agreement will automatically be renewed for a further year on May 31, 2023.

 

The employment agreement with Mr. Saunders was amended as follows. In addition to his cash compensation, the Company agreed to further compensate Mr. Saunders in accordance with our May 25, 2022, Equity Incentive Plan with 3,000,000 restricted stock units, which vests 1,500,000 annually over a period of two years. He was also entitled to health and vacation benefits and nine-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He was also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Saunders agreed to a two-year non-solicit restrictive covenant.

 

On January 31, 2023, Steven Saunders and Rik Willard entered into a separation agreement with the Company regarding the terms and conditions of their departures from the Company.

 

Pursuant to the provisions of the Separation Agreement with Mr. Saunders and in consideration for a complete release of claims, we agreed as follows:

 

  As of the Separation Agreement date, Mr. Saunders is no longer an officer or director of our company, and all prior agreements with Mr. Saunders, including his employment agreement, are terminated in their entirety.
  In satisfaction of all amounts due Employee, the Company agrees to pay Employee the total sum of $116,000, payable according to the following schedule:

 

  We agreed to pay a lump sum of $12,000 by February 10, 2023
  We agreed to pay a lump sum of $12,000 by February 20, 2023
  We agreed to pay $73,500 in six monthly installments commencing on February 28, 2023; and
  Final payment of $18,000 due by August 31, 2023.

 

Mr. Saunders forfeited 3,000,000 non-vested Restricted Stock Units awarded on May 31, 2022, under the 2022 Equity Incentive Plan.

 

Pursuant to the provisions of the Separation Agreement with Mr. Willard and in consideration for a complete release of claims, we agreed as follows:

 

  As of the date of the Separation Agreement, Mr. Willard is no longer an officer or director of our company, and all prior agreements with Mr. Willard, including his employment agreement, are terminated in their entirety.
  In satisfaction of all amounts due Employee, the Company agrees to pay Employee the total sum of $112,418, according to the following schedule:

 

  We agreed to pay a lump sum of $12,801 by February 20, 2023
  We agreed to pay a total of $76,806 in six monthly installments commencing February 28, 2023
  We agreed to pay a total of $4,806 in six monthly installments commencing August 31, 2023
  The final payment of $18,000 is due by September 30, 2024; and

 

  Our shareholder, Stephen Morris, has transferred to Mr. Willard 1,750,000 shares of his common stock.

 

Mr. Willard forfeited 5,400,000 non-vested Restricted Stock Units awarded on May 31, 2022, under the 2022 Equity Incentive Plan.

 

NOTE 12 - SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the date of issuance of this Quarterly Report on Form 10-Q and determined there were no subsequent events that would require adjustments to our disclosures in the consolidated financial statements.

 

F-21

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors that could have a material adverse effect on our operations and future prospects on a consolidated basis include but are not limited to: changes in economic conditions, pandemics, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements, and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.

 

Business Overview

 

Bubblr, Inc. (DBA: “Ethical Web AI”) (the “Company”) is a revolutionary technology company that aims to redefine Internet search. With its focus on anonymity, fairness, and ethical principles, Bubblr, Inc. presents a unique approach to the future of the Internet. The Company boasts two groundbreaking products: an Open-Source platform for building community super apps and an anonymous consumer app as an alternative to Chat GPT. Ethical Web AI is a company founded on the principles of digital disruption, innovation, and the emerging importance of ethical Internet applications. We call this emergent global movement the “Ethical Web.”

 

Ethical Web AI is more than just a technology company; it represents a paradigm shift in the online landscape. The Company’s vision is rooted in the belief that the future of the Internet lies in anonymity and fairness. By fixing search, Ethical Web AI aims to address broader issues in the online world while ensuring consumer anonymity. This approach enables small businesses to compete effectively, driving revenue for local communities.

 

Bubblr’s Mission

 

Ethical Web AI is on a mission to transform how users interact with the Internet, offering innovative solutions that prioritize consumer privacy and enhance the user experience.

 

Products

 

Ethical Web AI’s product portfolio consists of two innovative offerings.

 

1. AI Seek Apps: Empowering Anonymity and Enhanced User Experience

 

The AI Seek app is an enhanced version of Chat GPT, offering anonymous access to the technology without any registration requirements. The app provides a significantly improved user experience over traditional Chat GPT services, making it an attractive option for consumers seeking a more private and seamless search experience. AI Seek ensures that the app remains advertisement-free, providing a refreshing alternative to traditional search engines that rely heavily on advertising and consumer data.

 

2. Open-Source SaaS Platform for Goods and Services: Empowering Business and Community

 

4

 

 

Ethical Web AI’s Open-Source SaaS platform for Goods and Services is a game-changer for businesses and consumers. The platform will exclusively work in apps (mobile or desktop), providing an anonymous search mechanism for consumers even when interacting with suppliers.

 

At the heart of the platform’s efficiency is Zero Party Data derived from suppliers registered through licensees. This data is continually updated in real-time, ensuring highly accurate and up-to-date information, unlike traditional search engines that rely on less reliable web-crawled data.

 

The platform’s unique subscription model will enable merchants to be listed on the platform, generating recurring revenue for Ethical Web AI.

 

Patents

 

1. Internet-Based Search Mechanism for Goods and Services

 

We have created a new Internet-Based Search Mechanism, which has been granted a patent in South Africa (2016/06947), New Zealand (725014), the United States of America (‘Utility Patent No. U.S. 10977387, Canada (2962520), and Australia (2015248619), and we have patents pending on the same processes in the European Union (15723990.6) and the United Kingdom (PCT/GB2015/051130).

 

This utility patent grants Ethical Web AI the advantage of asynchronous search and client anonymity, making its apps uniquely secure and user-friendly. The patent’s title, “Internet Search Mechanism for Goods and Services that Only Works in Apps,” reflects the Company’s commitment to providing app-exclusive services that enhance user privacy and security.

 

2. Contextual Enveloping of Dynamic Hypertext Links

 

US Patent Application No 17/980298: Contextual Enveloping of Dynamic Hypertext Links is a sister patent to our approved Internet-Based Search Mechanism patent that will define an alternative mobile search system purely for information rather than goods and services. This utility patent represents a significant advancement in the user experience, enhancing access to Chat GPT through Ethical Web AI’s AI Seek app. The patent enables anonymous access to Chat GPT, delivering results in web pages that can be shared across various platforms.

 

3. Real-Time Data Processing

 

US Patent Application No 18376101: Real-Time Data Processing in AI Models. This patent encompasses a groundbreaking methodology allowing AI models to handle queries that necessitate real-time, up-to-date information, heralding a transformative shift in AI capabilities.

 

Competition

 

The space for online marketplaces and ad networks is rapidly evolving. The Advertising Technology (Ad-tech) industry includes all kinds of tools, software platforms (Google, Facebook), agencies, data brokers, etc. It facilitates targeted advertisements that have become exponentially more invasive over the past decade due to massive amounts of personal data collection. It is a complex and opaque ecosystem that tracks, profiles, discriminates (both personal and business), and manipulates for profit. It is a multi-billion-dollar industry that is now facing litigation, investigations, and new regulations to curb its practices.

 

We face intense competition from companies with much larger capital resources than us, and, as a result, we could struggle to attract users and gain market share. Many of our existing or future competitors have greater financial resources and greater brand name recognition than we do and, as a result, may be better positioned to adapt to changes in the industry or the economy. We will strive to advance our technology in each of these sectors ahead of our competitors to gain market share. We also face intense competition in attracting and retaining qualified employees. Our ability to continue to compete effectively will depend upon our ability to attract new employees, retain and motivate our existing employees, and compensate employees competitively. We face significant competition in several aspects of our business, and such competition might increase, particularly in the market for networks and online marketplaces. A key advantage against better-resourced competitors is provisioning our technology and related acquisitions as an open-source SAAS platform. This pushes all consumer and merchant marketing responsibility to the registered partners.

 

5

 

 

Our competitors may announce new products, services or enhancements that better address changing industry standards or the needs of users, such as mobile access or different market focus. Any such increased competition could cause pricing pressure, loss of business or decreased user activity, any of which could adversely affect our business and operating results.

 

We believe that we have competitive strengths and protection via our IP, which is defensible under the umbrella protection of our granted patents.

 

Results of Operation

 

Revenues

 

   Three Months Ended September 30, 2023   Nine Months Ended September 30, 2023 
   2023   2022   Change   2023   2022   Change 
Sales  $1,151   $-   $1,151    100%  $1,151   $-   $1,151    100%
Total revenue  $1,151   $-   $1,151    100%  $1,151   $-   $1,151    100%

 

In the three months and nine months ended September 30, 2023, revenues were $1,151.We did not achieve revenues from operations in 2022. We will not achieve higher revenues unless we are able to develop, market, support and deliver our products and service offerings. There can be no assurances we can achieve significant revenues despite our efforts.

 

Operating Expenses

 

   Three Months Ended September 30, 2023   Nine Months Ended September 30, 2023 
   2023   2022   Change   2023   2022   Change 
General and administrative  $1,016,034   $172,600   $843,434    489%  $2,211,310   $513,519   $1,697,791    331%
Professional fees   13,878    160,794    (146,916)   (91)   178,612    2,449,350    (2,270,738)   (93)
Sales and marketing   93,125    63,300    29,825    47    511,141    145,488    365,653    251 
Amortization and depreciation   54,331    60,234    (5,903)   (10)   176,840    268,688    (91,848)   (34)
Research and development   59,889    53,132    6,757    13    151,160    167,087    (15,927)   (10)
Total operating expenses  $1,237,257    510,060   $727,197    143%  $3,229,063   $3,544,132   $(315,069)   (9)%

 

General and administrative

 

General and administrative expenses consist mainly of compensation and costs associated with non-specific costs of running the business. These include, but are not limited to, office costs, computer software, and telecoms.

 

The increase in general and administrative costs was primarily due to accrued compensation, director fees for new executives, and stock options awarded offset by the forfeiture of restricted stock units in the nine months ended September 30, 2022.

 

Professional fees

 

Professional fees consist of costs in relation to legal, accounting, and consultants.

 

6

 

 

The decrease in professional fees was primarily due to issuing shares of common stock valued at $1,993,081 in 2022 for consulting services.

 

Sales and Marketing

 

Sales and marketing costs are costs incurred specifically in relation to fees and expenses for investor relations, advertising, marketing, press releases, and public relations.

 

The cost increase is primarily due to new investor relations services contracts paid for by issuing shares of common stock.

 

Amortization and depreciation

 

A significant portion of the amortization and depreciation costs are from the amortization of patents and intellectual property. Most of the patents and intellectual property are held in the UK subsidiary, Bubblr Ltd.

 

The reduction in costs is primarily due to lower amortization of Intellectual Property as IP added in 2016 of $1.68m (£1.3m) is fully amortized.

 

Research and Development

 

Costs incurred in relation to the development of the Company’s platform include costs associated with development staff and specialist software for product development and deployments.

 

Other Income (Expense), Net

 

   Three Months Ended September 30, 2023   Nine Months Ended September 30, 2023 
   2023   2022   Change   2023   2022   Change 
Interest income  $29   $389   $(360)   (93)%  $142    1,243    (1,101)   (89)%
Interest expense   (7,704)   (102,088)   94,384    (92)   (9,450)   (547,352)   537,902    (98)
Gain on change in fair value of warrant derivative liability   117,515    133,096    (15,581)   -    114,984    384,383    (269,399)   (70)
Foreign currency transaction loss   (44,937)   (127,776)   82,839    (65)   (6,520)   (289,790)   283,270    (98)
   $64,903   $(96,379)  $161,282    (167)%  $99,156   $(451,516)  $550,672    (122)%

 

Interest Income

 

The Company earns interest income from its cash reserves and advances receivable. The decrease of interest is due to the loss of interest from the Company’s advances receivables, which were repaid in 2022.

 

Interest Expense

 

Interest expense consists of interest on borrowings, a Company vehicle, convertible notes, and related party loans.

 

Gain on change in fair value of warrant derivative liability.

 

The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 11) for derivative accounting consideration under ASC 815, Derivatives and Hedging. ASC 815 requires us to assess the fair market value of the derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense items.

 

The market price of the common stock has decreased from the initial award of warrants in the period ending September 30, 2023. If the warrants were exercised at September 30, 2023 at their respective exercise price determined at issue, the Company would realize a gain due to the difference between the cash received on conversion and the issue cost to the Company of $0.06 per share, the fair value market price of the common stock at September 30, 2023.

 

7

 

 

Foreign currency translation gain (loss)

 

The gains and losses on foreign currency translation are due to the fluctuations in the U.S. dollar and British Pound Sterling exchange rates.

 

Net Loss after income tax

 

The net loss after income tax was $1,171,203 and $606,439 for the three months ended September 30, 2023, and 2022, respectively.

 

The net loss after income tax was $3,128,756 and $3,995,648 for the nine months ended September 30, 2023, and 2022, respectively.

 

Liquidity and Capital Resources

 

The following table provides selected financial data about our Company on September 30, 2023, and December 31, 2022.

 

   Nine Months Ended   Year Ended         
   September 30, 2023   December 31, 2022   Change 
                 
Current Assets  $10,753   $42,417   $(31,664)   (75)%
Current Liabilities   2,436,789    595,856    1,840,933    309 
                     
Working Capital Deficit  $(2,426,036)  $(553,439)  $(1,872,597)   338%

 

Current Assets

 

Current assets consist of cash and other receivable.

 

The decrease in current assets was primarily due to a decrease in cash.

 

Current Liabilities

 

Current Liabilities consist of accounts payable, accrued liabilities, and loans.

 

The increase in current liabilities was primarily due to increases of $151,644 in accounts payable, $143,750 in accrued director fees, $900,521 in accrued wages and salaries, $154,185 for a settlement agreement with former executives, and $422,412 in additional related-party loans.

 

Working Capital Deficit

 

The working capital deficit increased by $1,872,597.

 

Liquidity

 

During the last two years, and through the date of this Report, we have faced an increasingly challenging liquidity situation that has limited our ability to execute our operating plan. We will need to obtain capital to continue operations. There is no assurance that we can secure such funding on acceptable terms.

 

As no revenues are generated from our current operations, we will require additional debt or capital to continue operating and expanding our business. Sources of additional financing or arrangements with third parties may include equity or debt financing, bank loans, related-party loans, or revolving credit facilities. We may not be successful in locating suitable financing transactions in the period required or at all, and we may not obtain the capital we require by other means. Unless we can attract additional investment, our operating as a going concern is in doubt.

 

8

 

 

We voluntarily file annual, quarterly, and current reports with the SEC pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In addition, the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”) and the rules subsequently implemented by the SEC and the Public Company Accounting Oversight Board (“PCAOB”) have imposed various requirements on public companies, including requiring changes in corporate governance practices. We expect these rules and regulations to increase our legal and financial compliance costs and to make some activities of ours more time-consuming and costly. To meet the needs to comply with the requirements of the Exchange Act, we will need an investment of capital.

 

If we are unable to obtain sufficient additional capital, we may have to cease filing our SEC reports and cease operations completely. If we obtain additional funds by selling any of our equity securities or by issuing common stock to pay current or future obligations, the percentage ownership of our stockholders will be reduced, and stockholders may experience additional dilution, or the equity securities may have rights preferences or privileges senior to the common stock.

 

Cash Flow

 

  

Nine Months Ended

September 30,

         
   2023   2022   Change   % 
Cash used in Operating activities  $(412,603)  $(1,363,863)  $951,260    (70)%
Cash used in Investing Activities   (21,935)   (18,282)   (3,653)   20 
Cash provided by Financing Activities   382,970    1,181,636    (798,666)   (68)
Cash on Hand  $1,660   $154,780   $(153,120)   (99)%

 

Operating Activities

 

The decrease in net cash used in operating activities was primarily due to increased accrued liabilities.

 

Investing Activities

 

Net cash used in investing activities was on Patents and Trademarks.

 

Financing Activities

 

The reduction in net cash provided by financing activities was primarily due to $789,000 received in 2022 from Series C Preferred Stock issuance.

 

Cash on Hand

 

The reduction of cash on hand was primarily due to a reduction in fundraising in 2023.

 

The Company is currently exploring future fundraising options, including equity, debt, the sale of/or the licensing of the Company’s Patent(s) and/or IP, with a holdback of the Company’s rights to use the IP to secure funding for operations. If we cannot secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all. [if Jorge’s cash hits your bank before we file the 10-Q, we can put deleted language back in]

 

9

 

 

Critical Accounting Policies and Significant Judgments and Estimates

 

This discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). Preparing these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and various other factors that we believe are reasonable under the circumstances, which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. While our significant accounting policies are described in more detail in the notes to our financial statements included elsewhere in this Report, we believe that the following accounting policies are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

 

We believe our most critical accounting policies and estimates relate to the following:

 

  Foreign Currency Translations
  Intangible Assets
  Long-lived Assets
  Income Taxes
  Stock-based Compensation
  Common Stock Purchase Warrants and Derivative Financial Instruments
  Convertible Financial Instruments
  Fair Value of Financial Instruments

 

Foreign Currency Translations

 

The functional currency of the Company’s international subsidiaries is generally their local currency of Great British Pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income.

 

Intangible Assets

 

The cost of intangible assets with determinable useful lives is amortized to reflect the pattern of economic benefits consumed on a straight-line basis over the estimated periods benefited. Patents, technology and other intangibles with contractual terms are generally amortized over their respective legal or contractual lives. When certain events or changes in operating conditions occur, an impairment assessment is performed, and lives of intangible assets with determinable lives may be adjusted.

 

Long-Lived Assets

 

Long-lived assets are evaluated for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on comparing the undiscounted future cash flows to the recorded value of the asset. The asset is written down to its estimated fair value if an impairment is indicated.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax bases of assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

10

 

 

Convertible Financial Instruments

 

The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. These criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.

 

Fair Value of Financial Instruments

 

The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC Topic 718 Compensation - Stock Compensation which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expenses in the financial statements based on the stock awards’ fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). Stock Options awarded as compensation per the Company’s 2022 Equity Incentive Plan are deemed to be unissued until vested. Stock Option compensation is recognized as an expense over the vesting period. Awards forfeited due to unfulfillment of obligations, such as termination of employment prior to the award being fully vested, for no cash or other consideration, are not recognized as an expense, and any previously recognized costs are reversed in the period of forfeiture.

 

Common Stock Purchase Warrants and Derivative Financial Instruments

 

Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

 

Recent Accounting Pronouncements

 

For discussion of recently issued and adopted accounting pronouncements, please see Note 2 to the unaudited consolidated financial statements as of and for the quarters ended September 30, 2023, and 2022 included herein.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2023, there were no off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable.

 

11

 

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in our reports is recorded, processed, summarized, and reported within the periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our chief executive officer and our chief financial officer, as appropriate, to allow timely decisions regarding required disclosures. However, our chief executive officer and our chief financial officer have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period being reported by this Form 10-Q and have concluded that we have material weaknesses and significant deficiencies in our internal control over financial reporting as described below. Accordingly, our disclosure controls and procedures were not effective or sufficient to accomplish their objectives at the reasonable assurance level as of September 30, 2023.

 

Management’s Report of Internal Control over Financial Reporting

 

Our chief executive officer and our chief financial officer are responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rule 13a-15(f) under the Exchange Act. An evaluation was performed of the effectiveness of our internal control over financial reporting. The evaluation was based on the framework in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness in future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

Based on our evaluation under the criteria set forth in the 2013 Internal Control-Integrated Framework, our management concluded that as of September 30, 2023, our internal control over financial reporting was not effective because of the identification of material weaknesses described as follows:

 

 

  We did not have controls designed to validate the completeness and accuracy of underlying data used in the determination of accounting transactions. Accordingly, we have a material weakness because there is a reasonable possibility that a material misstatement to the interim or annual consolidated financial statements would not be prevented or detected on a timely basis.
     
  We have limited written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act, which is applicable to us. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.
     
  We do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets, and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.
     
  We have insufficient personnel with the requisite expertise in the key functional areas of finance and accounting.
     
  We do not have a functioning audit committee and only one outside director on our board of directors, resulting in ineffective oversight in establishing and monitoring required internal controls and procedures.

 

Remediation Plan to Address the Material Weaknesses in Internal Control over Financial Reporting

 

Our Management is committed to improving its internal controls when we have adequate resources to do so, and we appointed a full-time chief financial officer in February 2023. We will appoint outside directors and establish an audit committee in 2024. Due to the nature of these material weaknesses, misstatements that could be material to the annual or interim consolidated financial statements could occur that would not be prevented or detected during our financial close and reporting process.

 

Our Company plans to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have been unable to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management, and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we do not secure such funds, remediation efforts may be materially affected.

 

Changes in Internal Control over Financial Reporting

 

In the three months ended September 30, 2023, there were no material changes in our internal control over financial reporting that materially affected or are reasonably likely to affect our internal control over financial reporting.

 

12

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not a party to any pending legal proceedings. We are unaware of any pending legal proceeding to which any of our officers, directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse to us.

 

Item 1A: Risk Factors

 

Not applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

The information set forth below relates to our issuances of securities without registration under the Securities Act of 1933.

 

In the nine months ended September 30, 2023, the Company issued the following unregistered securities:

 

  311,159 shares for dividend due of Series C Preferred Stock valued at $43,805.
  2,580,784 shares for consulting services valued at $450,338.

 

These securities were issued pursuant to the exemption from registration contained in Section 4.(a)(2) of the Securities Act of 1933, as amended, and/or the exception from registration contained in Regulation S promulgated thereunder. The holders represented their intention to acquire the securities for investment only and not with a view toward distribution. The investors were given adequate information about us to make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock.

 

Item 3. Defaults upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

See Exhibit Index below for exhibits required by Item 601 of Regulation S-K.

 

Exhibit Number   Description of Exhibit
     
31.1**   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2**   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101**   The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Extensible Business Reporting Language (XBRL).
     
    **Provided herewith

 

13

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BUBBLR, INC.
   
Date: November 14, 2023 /s/ Timothy Burks
  Timothy Burks
  President and Chief Executive Officer
  (Principal Executive Officer)
   
Date: November 14, 2023 /s/ David Chetwood
  David Chetwood
  Chief Financial Officer
  (Principal Accounting and Financial Officer)

 

14